|
ARID1B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.484202064172E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.97269986404558E-11 |
| Normal-vs-Stage2 |
5.3204999994616E-07 |
| Normal-vs-Stage3 |
8.36589999497761E-08 |
| Normal-vs-Stage4 |
2.58100000039008E-07 |
| Stage1-vs-Stage2 |
9.254200E-01 |
| Stage1-vs-Stage3 |
9.256400E-01 |
| Stage1-vs-Stage4 |
4.832000E-01 |
| Stage2-vs-Stage3 |
8.612600E-01 |
| Stage2-vs-Stage4 |
3.796800E-01 |
| Stage3-vs-Stage4 |
4.730000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.21179741188848E-11 |
| Normal-vs-AfricanAmerican |
2.43690000401031E-08 |
| Normal-vs-Asian |
7.22159999577698E-08 |
| Caucasian-vs-AfricanAmerican |
7.377800E-01 |
| Caucasian-vs-Asian |
4.180800E-01 |
| AfricanAmerican-vs-Asian |
3.345000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.42934619274638E-12 |
| Normal-vs-Female |
2.67279999999204E-06 |
| Male-vs-Female |
2.637700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.89760000332851E-08 |
| Normal-vs-Extreme_Weight |
2.15305551165557E-12 |
| Normal-vs-Obese |
1.20619999999239E-06 |
| Normal-vs-Extreme_Obese |
4.54270000005419E-06 |
| Normal_Weight-vs-Extreme_Weight |
3.425200E-01 |
| Normal_Weight-vs-Obese |
1.602380E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.341800E-01 |
| Extreme_Weight-vs-Obese |
4.864900E-03 |
| Extreme_Weight-vs-Extreme_Obese |
8.565200E-01 |
| Obese-vs-Extreme_Obese |
1.900830E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.70620000000366E-05 |
| Normal-vs-Age(41-60Yrs) |
1.14070000112321E-08 |
| Normal-vs-Age(61-80Yrs) |
3.61022323147608E-12 |
| Normal-vs-Age(81-100Yrs) |
2.84309999987187E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.284200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.065600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.629800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.226300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.463700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.059600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.35089766834562E-11 |
| Normal-VS-Type2 PRCC |
8.11362088626311E-12 |
| Normal-VS-KIRP CIMP |
1.256840E-03 |
| Normal-VS-Unclassified PRCC |
1.97196999999205E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.788220E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.349600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.884400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.726380E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.673210E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.946400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.55111512312578E-15 |
| Normal-vs-N1 |
3.12920000000716E-06 |
| Normal-vs-N2 |
8.00069999999931E-05 |
| N0-vs-N1 |
2.076300E-02 |
| N0-vs-N2 |
6.310000E-01 |
| N1-vs-N2 |
1.855190E-01 |
|
|
